$HTFL

Farquhar John C.M. sold $1.4M of HTFL

Farquhar John C.M. (Chief Executive Officer) sold 38,900 shares of Heartflow, Inc. (HTFL) at $35.00 ($1.36M total) on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Farquhar John C.M.
Published Jun 26, 2026, 10:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HTFL
Neutral
medium confidence
Mentioned
$HTFL
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLNeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size ($1.36M) and execution details (38,900 shares at $35.00) under a 10b5-1 plan; this can influence short-term sentiment but does not change fundamentals by itself.

02

Market read

Traders may monitor HTFL for sentiment drift around insider activity, but the 10b5-1 structure limits interpretive weight.

03

What to watch

The filing provides post-transaction share count and exact execution price, but it does not disclose reasons for sale or any concurrent operational updates.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-26 after-hours; reflects sale executed 2026-06-24.

Background

The article is an SEC Form 4 insider transaction disclosure for Heartflow, Inc. (HTFL).

Company-level read

Ticker impact

$HTFLNeutralMedium confidence
Context

Heartflow CEO Farquhar sold 38,900 shares at $35.00/share under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited/short-lived impact; any reaction would be sentiment-driven rather than a new business catalyst.

Evidence & confidence

The filing is primary-source and time-stamped, but it is an open-market sale under a 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide regulatory/product change.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may be routine liquidity rather than a bearish signal; traders may ignore it unless paired with other negative catalysts.

Key entities

  • Heartflow, Inc.

    Subject of the Form 4 insider transaction; CEO Farquhar sold shares under a 10b5-1 plan.

  • Farquhar John C.M.

    CEO and officer/director who executed the open-market sale disclosed in the filing.

Related articles